Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind, placebo-controlled study of pharmacodynamic effects of 4 mg nicotine gum in healthy smokers willing to quit
2018-004229-10Phase 4Completed
- Sponsor
- McNeil Laboratories
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in nicotine dependence comparing Nicorette Freshfruit 4 mg nicotine gum with Placebo gum (2 arms). Primary endpoint: Mean daily self-assessed VAS ratings of overall relief of withdrawal symptoms over Days 1 and 2. Started May 2019; status: completed.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2018-004229-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004229-10.